Home › Learn › Stopping GLP-1

The Maintenance Phase

What happens when you stop GLP-1 injections?

Injectable GLP-1 medications quiet appetite signals while you take them. When the medication stops, those signals come back — and that's exactly when most plans fall apart. Here's what to expect, and why the phase after injections deserves as much attention as the weight-loss phase itself.

Woman using a needle-free sublingual maintenance spray

Appetite signaling returns first

GLP-1 receptor agonists work in part by supporting satiety — the feeling of fullness that tells you to stop eating. As the medication leaves your system over the weeks after your last dose, many people notice hunger returning to pre-treatment levels, and sometimes cravings — especially for sugar and refined carbohydrates — resurface before anything shows on the scale.

What the research suggests about weight regain

Published research on GLP-1 discontinuation has reported that many patients regain a significant share of lost weight within a year of stopping — figures around 60–70% of lost weight regained within 12 months are commonly cited. Researchers increasingly describe obesity as a chronic, relapsing condition: when treatment stops without a maintenance plan, the underlying biology tends to reassert itself. Individual results vary widely.

Why "willpower" isn't a maintenance plan

The return of appetite after stopping a GLP-1 isn't a character flaw — it's physiology. Hormonal signals that drive hunger were suppressed by medication, not retrained. That's why clinicians often talk about a maintenance phase: a deliberate plan for the months after weight loss, which may include nutrition and activity strategies, ongoing provider check-ins, and — for some patients — continued medication support in a different form.

Building a maintenance plan

Wondering where you stand? Your own licensed healthcare provider is the right person to ask, and our list of questions for your provider can help you prepare.

Important safety information

  • • This article is educational only and is not medical advice. Always consult a licensed healthcare provider about starting, stopping, or changing any medication.
  • • THIN™, THIN-R™, and THIN-ST™ are prescription-only compounded medications, prepared by licensed 503A pharmacies. They are not FDA-approved, and are dispensed only if a licensed provider determines they are medically appropriate.
  • • A prescription is never guaranteed. Individual results vary.
Built for the Next Phase

Have a plan before the last injection.

A licensed provider can help you decide what the maintenance phase should look like for you.

Questions for Your Provider